-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

201.O2.6 201. Granulocytes, Monocytes, and Macrophages: Uncovering Pathways Impacting Inflammation, Myeloid Proliferation and Severe Congenital Neutropenia

Symposia: Granulocytes, Monocytes, and Macrophages Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Acute Myeloid Malignancies, AML, Translational Research, Inherited Marrow Failure Syndromes, Drug development, Genetic Disorders, Clinical Research, Bioinformatics, Hematopoiesis, Diseases, Immune Disorders, Neutropenia, Treatment Considerations, Adverse Events, Biological Processes, Myeloid Malignancies, Molecular biology, Technology and Procedures, Gene editing, Omics technologies
Sunday, December 8, 2024: 9:30 AM-11:00 AM
Grand Hall D (Manchester Grand Hyatt San Diego)
Moderators:
Julia T. Warren, MD, PhD, and Carlo Dufour, MD, IRCCS Istituto Giannina Gaslini
Disclosures:
Warren: X4 Pharmaceuticals: Consultancy, Research Funding. Dufour: Novartis: Consultancy; Sobi: Consultancy; Pfizer: Consultancy, Speakers Bureau; Gilead: Consultancy; Ono: Consultancy; Rockets: Consultancy.
In this exciting oral session new molecular pathways involved in inflammation and in myeloid cell proliferation will be presented. New disease-genes and agent potentially restoring granulopoiesis will be also illustrated.
9:30 AM

Katie Frenis, PhD1,2,3, Brianna Badalamenti, MS1,3*, Edroaldo Lummertz Da Rocha, PhD4*, Chen Weng, PhD5,6,7,8*, Dahai Wang, PhD1,9*, Sara Fierstein, MS1,10*, R. Grant Rowe, MD, PhD1,2,9,11,12 and Vijay G. Sankaran, MD, PhD7,8,13,14

1Stem Cell Program, Boston Children's Hospital, Boston, MA
2Harvard Medical School, Boston, MA
3Boston Children's Hospital, Boston, MA
4Federal University of Santa Catarina, Florianopolis, BRA
5Whitehead Institute for Biomedical Research, Cambridge, MA
6Division of Hematology/Oncology, Boston Children’s Hospital, Harvard Medical School, Boston, MA
7Broad Institute of MIT and Harvard, Cambridge, MA
8Howard Hughes Medical Institute, Boston, MA
9Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, MA
10Division of Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, MA
11Dana-Farber Boston Children’s Cancer and Blood Disorders Center, Boston, MA
12Stem Cell Transplantation Program, Boston Children’s Hospital, Boston, MA
13Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA
14Division of Pediatric Oncology, Dana-Farber Cancer Institute / Harvard Medical School, Boston, MA

9:45 AM

Charles Antony, PhD1, Subin S George1*, Justin Blum1*, Patrick Somers1*, Dexter Wu-Corts1*, Santosh Adhikari, PhD2*, Maxim Pimkin, MD, PhD3, Mustafa Mir, PhD2* and Vikram R Paralkar, MD1

1Department of Medicine, University of Pennsylvania, Philadelphia, PA
2The Children’s Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA
3Dana-Farber Cancer Institute, Brookline, MA

10:00 AM

Natalia Alejandra Borbaran Bravo, MSc1*, Ekaterina Deordieva, MD, PhD2*, Larissa Doll3*, Mohammad Elgamacy, PhD4,5*, Benjamin Dannenmann, PhD3*, Joana Azevedo6*, Alberto Iannuzzo7*, Selket Delafontaine8,9*, Moritz Lehners10*, Marius Kolodziej11*, Birte Hernandez Alvarez12*, Anna-Sophia Hellmuth5*, Malte Ulrich Ritter13*, Betül Findik3*, Viktoria Zakharova14*, Sandro Bräuning5*, Sergey Kandabarau3*, Claudia Lengerke, MD15, Robert Feil16*, Isabelle Meyts, MD, PhD8,17*, Jerome Delon7*, Markus Templin18*, Marc Sturm19*, Olaf Rieß19*, Cornelia Zeidler, MD20*, Karl Welte, MD, PhD20,21, Anna Shcherbina22*, Maksim Klimiankou, PhD21* and Julia Skokowa, MD, PhD21

1Department of Oncology, Hematology, Clinical Immunology, and Rheumatology, University hospital tuebingen, Tubingen, Germany
2Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation
3Department of Oncology, Hematology, Clinical Immunology, and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany
4Department Protein Evolution, Max Planck Institute for Biology Tuebingen,, Tuebingen, Germany
5Department of Oncology, Hematology, Clinical Immunology, and Rheumatology, University Hospital Tuebingen, Tuebingen, DEU
6Faculty of Medicine, University of Coimbra, Coimbra, Portugal
7Université Paris Cité, CNRS, Inserm, Institut Cochin, Paris, FRA
8Department of Pediatrics, University Hospital Leuven, Leuven, Belgium
9Laboratory for Inborn Errors of Immunity-Department of Microbiology Immunology Transplantation, KU Leuven, Leuven, BEL
10Interfaculty Institute of Biochemistry, University of Tuebingen, Tueingen, DEU
11NMI Natural and Medical Sciences Institute,, University of Tuebingen, Reutlingen, Germany
12Department Protein Evolution, Max Planck Institute for Biology, Tuebingen, Germany
13Department of Oncology, Hematology, Clinical Immunology, and Rheumatology, University Hospital Tuebingen, Tuebingen, BW, Germany
14National Medical Research Center for Endocrinology, Clinical data analysis department, Moscow, Russian Federation
15Department for Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany
16Interfaculty Institute of Biochemistry, University of Tuebingen, Tuebingen, DEU
17Laboratory for Inborn Errors of Immunity-Department of Microbiology Immunology Transplantation, KU Leuven, Leuven, AL, BEL
18NMI Natural and Medical Sciences Institute, University of Tuebingen, Reutlingen, DEU
19Institute of Medical Genetics and Applied Genomics, University Hospital Tuebingen, Tuebingen, DEU
20University Children’s Hospital Tübingen, Tübingen, Germany
21Department of Oncology, Hematology, Immunology, Rheumatology and Clinical Immunology, University Hospital Tübingen, Tübingen, Germany
222Department of Immunology, Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, RUS

10:15 AM

Chi Nguyen, PhD1*, Robert Johnson2*, Katarina Zmajkovicova1*, Angelina Sekirnik3*, Sarah Taplin4*, Myriam Defontis5*, Jacob R. Bledsoe6, Lars Karlsson1* and Arthur G. Taveras2*

1X4 Pharmaceuticals (Austria) GmbH, Vienna, Austria
2X4 Pharmaceuticals Inc., Boston, MA
3Research & Development Consultant for X4 Pharmaceuticals, Boston, MA
4Integrated Biologix GmbH, Basel, Switzerland
5Defontis Veterinary Clinical Pathology, Bully, France
6Department of Pathology, Boston Children's Hospital, Boston, MA

10:30 AM

Benjamin Dannenmann, PhD1*, Masoud Nasri, PhD1,2*, Larissa Doll1*, Betül Findik1*, Franka Bernhard1*, Sergey Kandabarau1*, Maksim Klimiankou, PhD3*, Claudia Lengerke, MD1, Cornelia Zeidler, MD4*, Karl Welte, MD, PhD3,5 and Julia Skokowa, MD, PhD2,3

1Department of Oncology, Hematology, Clinical Immunology, and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany
2Gene and RNA Therapy Center (GRTC), University Hospital Tuebingen, Tuebingen, Germany
3Department of Oncology, Hematology, Immunology, Rheumatology and Clinical Immunology, University Hospital Tübingen, Tübingen, Germany
4Severe Chronic Neutropenia International Registry, Hannover Medical School, Hannover, Germany
5University Children’s Hospital Tübingen, Tübingen, Germany

10:45 AM

Xia Li1*, Haikun Lin1,2*, Boxiang Wu1,2*, Xinyi Lai1*, Yinnan Tong1*, Jinyan Huang3*, Pengxu Qian4*, Yongxian Hu1* and He Huang, MD1*

1Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
2Zhejiang University-University of Edinburgh Institute, Zhejiang University School of Medicine, Zhejiang University, Haining, China
3Biomedical big data center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
4Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, HANGZHOU, China

*signifies non-member of ASH